US EditionPublished • loading... • Updated
Lee Ainslie’s Maverick Capital Slashes Stakes in Lam Research, Dollar Tree, Rentokil, and More | The Acquirer's Multiple®
Summary by Stock Screener - The Acquirer's Multiple®
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lee Ainslie’s Maverick Capital Slashes Stakes in Lam Research, Dollar Tree, Rentokil, and More | The Acquirer's Multiple®
In the most recent quarter, Lee Ainslie of Maverick Capital made a series of significant reductions across his equity portfolio. Known for running a concentrated, high-conviction strategy with a strong emphasis on fundamental research, Ainslie appears to be exiting or dramatically trimming several positions where conviction may have waned or valuations no longer justified the exposure. Below are the top five reductions by percentage change in co…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
